Sanofi filed a complaint that alleged Seikagaku-developed and Zimmer-distributed Gel-One product infringed its patent for treating knee arthritis. A federal jury ruled last month that the patent includes administration through a single injection rather than multiple injections. The patent was also ruled invalid because it included “obvious variations of earlier work.”
More Articles on Orthopedic Devices:
14 Orthopedic & Spine Device Company Financial Reports
Smith & Nephew Looks for Merger or Acquisition Deal
Indian Market for Orthopedic Soft Tissue and Sports Medicine Devices Reached $17M in 2011
